has approved Novo Nordisk's Ozempic to lower the risk of kidney failure and disease progression. According to a statement made by the Danish pharmaceutical company, approval has also been obtained ...
Ozempic generated $13.9bn in global sales for Novo Nordisk in 2023. The drug is forecast to reach $23.9bn in sales by 2030, according to GlobalData’s Pharma Intelligence Center. GlobalData is the ...
Two separate courts today (28 January) set 8 April for submitting probe reports in three murder and murder attempt cases filed against Salman F Rahman, former private industry affairs adviser to ...
Barrister Zaima Rahman, daughter of BNP acting chairperson Tarique Rahman, will attend the 'National Prayer Breakfast' event in the United States on 5-6 February. "Tarique Rahman will not be attending ...
The High Court has issued a "standover" on a writ seeking prevention of the transfer of Tk230 crore worth of shares of Novartis Bangladesh Ltd ... the leadership of Salman F Rahman, who is also the ...
NEW YORK, NY / ACCESS Newswire / January 28, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities ...
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA ...
The Danish drug giant Novo Nordisk, known for its antidiabetes and weight loss ... the self-regulatory body that administers the code of practice of the Association of the British Pharmaceutical ...
The patent covers the oral administration of the drug to treat obesity. Credit: Cynthia A Jackson/Shutterstock. Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Novo Nordisk (NVO) has reportedly been criticized ... a self-regulatory body which administers the Association of the British Pharmaceutical Industry's Code of Practice, said in a report issued ...